Introduction to pharmacogenetics.

Drug interactions Pharmacy Polypharmacy

Journal

Drug and therapeutics bulletin
ISSN: 1755-5248
Titre abrégé: Drug Ther Bull
Pays: England
ID NLM: 0112037

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 2 11 2023
pubmed: 4 10 2023
entrez: 3 10 2023
Statut: ppublish

Résumé

There is considerable interindividual variability in the effectiveness and safety of medicines. Although the reasons for this are multifactorial, it is well recognised that genetic changes impacting the absorption or metabolism of these drugs play a significant contributory role. Understanding how these pharmacogenetic variants impact response to medicines, and leveraging this knowledge to guide prescribing, could have significant benefits for patients and health services. This article provides an introduction to the field of pharmacogenetics, including its nomenclature, the existing evidence base and the current state of implementation globally. We discuss the challenges in translating pharmacogenetic research into clinical practice and highlight the considerable benefits which can emerge in those health services where implementation is successful.

Identifiants

pubmed: 37788890
pii: dtb.2023.000009
doi: 10.1136/dtb.2023.000009
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-172

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared. Refer to the online supplementary files to view the ICMJE form(s).

Auteurs

John Henry McDermott (JH)

Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK john.mcdermott@mft.nhs.uk.
Division of Evolution, Infection and Genomics, School of Biological Sciences, The University of Manchester, Manchester, UK.

William Newman (W)

Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
Division of Evolution, Infection and Genomics, School of Biological Sciences, The University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH